The Hydrocephalus Shunts market covers Adjustable Valves, Monopressure Valves, etc. The typical players include Medtronic, Johnson & Johnson, Integra LifeSciences, SOPHYSA, B.BRAUN, etc.
CSF diversion devices or shunts have been used successfully and have become the primary therapy for hydrocephalus treatment for nearly 60 years.
An implanted shunt diverts CSF from the ventricles within the brain or the subarachnoid spaces around the brain and spinal cord to another body region where it will be absorbed.
Shunts typically consist of three major components:
An inflow (proximal or closer to the inflow site) catheter, which drains CSF from the ventricles or the subarachnoid space; this tube leaves the brain through a small hole in the skull and then runs for a short distance under the skin.
A valve mechanism, which regulates differential pressure or controls flow through the shunt tubing; this device is connected to the proximal catheter and lies between the skin and the skull, usually on top of the head or just behind the ear.
An outflow (distal or farther away from the inflow site) catheter, which runs under the skin and directs CSF from the valve to the abdominal (or peritoneal) cavity, heart or other suitable drainage site
Other shunt components may include reservoirs and/or chambers for CSF sampling or injecting medications or dyes, on/off devices, anti-siphon or other flow-compensating devices, or auxiliary catheters to modify performance or adapt the basic system to the patient’s specialized needs. In selected cases (such as when cysts or subarachnoid fluid collections are drained), a shunt may not contain a valve or a very low resistance valve may be used.
United States is the largest consumption place, with a consumption market share nearly 40.43% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 32.09%.
In 2020, the global Hydrocephalus Shunts market size was US$ 385.6 million and is forecast to 525.7 million US in 2027, growing at a CAGR of 5.3% during the 2021-2027. In this study, 2020 has been considered as the base year and 2021 to 2027 as the forecast period to estimate the market size for Hydrocephalus Shunts.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Hydrocephalus Shunts market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Hydrocephalus Shunts market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Hydrocephalus Shunts market. Readers of the report can become informed about current and future trends of the global Hydrocephalus Shunts market and how they will impact market growth during the forecast period.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Segment by Type
Adjustable Valves
Monopressure Valves
Segment by End User
Adult
Child
By Company
Medtronic
Integra LifeSciences
B.BRAUN
SOPHYSA
CSF diversion devices or shunts have been used successfully and have become the primary therapy for hydrocephalus treatment for nearly 60 years.
An implanted shunt diverts CSF from the ventricles within the brain or the subarachnoid spaces around the brain and spinal cord to another body region where it will be absorbed.
Shunts typically consist of three major components:
An inflow (proximal or closer to the inflow site) catheter, which drains CSF from the ventricles or the subarachnoid space; this tube leaves the brain through a small hole in the skull and then runs for a short distance under the skin.
A valve mechanism, which regulates differential pressure or controls flow through the shunt tubing; this device is connected to the proximal catheter and lies between the skin and the skull, usually on top of the head or just behind the ear.
An outflow (distal or farther away from the inflow site) catheter, which runs under the skin and directs CSF from the valve to the abdominal (or peritoneal) cavity, heart or other suitable drainage site
Other shunt components may include reservoirs and/or chambers for CSF sampling or injecting medications or dyes, on/off devices, anti-siphon or other flow-compensating devices, or auxiliary catheters to modify performance or adapt the basic system to the patient’s specialized needs. In selected cases (such as when cysts or subarachnoid fluid collections are drained), a shunt may not contain a valve or a very low resistance valve may be used.
United States is the largest consumption place, with a consumption market share nearly 40.43% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 32.09%.
In 2020, the global Hydrocephalus Shunts market size was US$ 385.6 million and is forecast to 525.7 million US in 2027, growing at a CAGR of 5.3% during the 2021-2027. In this study, 2020 has been considered as the base year and 2021 to 2027 as the forecast period to estimate the market size for Hydrocephalus Shunts.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Hydrocephalus Shunts market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Hydrocephalus Shunts market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Hydrocephalus Shunts market. Readers of the report can become informed about current and future trends of the global Hydrocephalus Shunts market and how they will impact market growth during the forecast period.
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Segment by Type
Adjustable Valves
Monopressure Valves
Segment by End User
Adult
Child
By Company
Medtronic
Integra LifeSciences
B.BRAUN
SOPHYSA
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.